From Medscape Oncology

Medscape Medical News from the:

35th European Society for Medical Oncology (ESMO) Congress

October 08 - 12, 2010; Milan, Italy

This coverage is not sanctioned by, nor a part of, the European Society for Medical Oncology.


Top News Stories From the 35th ESMO Congress: Slideshow
Positive results were seen with bevacizumab in ovarian cancer, cetuximab in triple-negative breast cancer, and abiraterone in metastatic prostate cancer.

Conference News

Medscape Oncology©  WebMD, LLC